Targeted Gene Silencing into Solid Tumors with Electrically Mediated siRNA Delivery

  • Muriel Golzio
  • Laurent Mazzolini
  • Aurélie Paganin-Gioanni
  • Justin Teissié
Part of the Methods in Molecular Biology™ book series (MIMB, volume 555)


Short interfering RNAs (siRNAs) represent new potential therapeutic tools, owing to their capacity to induce strong, sequence-specific gene silencing in cells. However, their clinical development requires new, safe, and efficient in vivo siRNA delivery methods. In this study, we report an efficient in vivo approach for targeting gene knockdown in solid tumors by the use of external electric field pulses. We show that gene silencing is efficiently obtained in vivo with chemically synthesized siRNA after targeted electrical delivery in the tumor-bearing mouse. The associated gene silencing was followed on the same animal by fluorescence imaging and confirmed by qPCR. Gene silencing obtained in tumors lasted from 2 to 4 days after a single treatment. Therefore, this method should allow gene function analysis or organ treatment by a localized delivery of siRNAs.

Key words

RNA interference siRNA tumor GFP fluorescence in vivo imaging electroporation mice therapy electropulsation 


  1. 1.
    Rana, T.M. (2007) Illuminating the silence: understanding the structure and function of small RNAs. Nat Rev Mol Cell Biol. 8, 23–36.PubMedCrossRefGoogle Scholar
  2. 2.
    de Fougerolles, A., et al. (2007) Interfering with disease: a progress report on siRNA-based therapeutics. Nat Rev Drug Discov. 6, 443–453.PubMedCrossRefGoogle Scholar
  3. 3.
    Kim, D.H. and J.J. Rossi. (2007) Strategies for silencing human disease using RNA interference. Nat Rev Genet. 8, 173–184.PubMedCrossRefGoogle Scholar
  4. 4.
    Behlke, M.A. (2006) Progress towards in vivo use of siRNAs. Mol Ther. 13, 644–670.PubMedCrossRefGoogle Scholar
  5. 5.
    Heller, L.C., K. Ugen, and R. Heller (2005) Electroporation for targeted gene transfer. Expert Opin Drug Deliv. 2, 255–268.PubMedCrossRefGoogle Scholar
  6. 6.
    Li, S. (2004) Electroporation gene therapy: new developments in vivo and in vitro. Curr Gene Ther. 4, 309–316.PubMedGoogle Scholar
  7. 7.
    Wells, D.J. (2004) Gene therapy progress and prospects: electroporation and other physical methods. Gene Ther. 11, 1363–1369.PubMedCrossRefGoogle Scholar
  8. 8.
    Golzio, M., et al. (2007) In vivo gene silencing in solid tumors by targeted electrically mediated siRNA delivery. Gene Ther. 14, 752–759.PubMedCrossRefGoogle Scholar
  9. 9.
    Caplen, N.J., et al. (2001) Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems. Proc Natl Acad Sci USA. 98, 9742–9747.PubMedCrossRefGoogle Scholar
  10. 10.
    Klein, D., et al. (2000) Accurate estimation of transduction efficiency necessitates a multiplex real-time PCR. Gene Ther. 7, 458–463.PubMedCrossRefGoogle Scholar
  11. 11.
    Vandesompele, J., et al. (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 3, 34.CrossRefGoogle Scholar
  12. 12.
    Birmingham, A., et al. (2007) A protocol for designing siRNAs with high functionality and specificity. Nat Protoc. 2, 2068–2078.PubMedCrossRefGoogle Scholar
  13. 13.
    Pei, Y. and T. Tuschl (2006) On the art of identifying effective and specific siRNAs. Nat Methods. 3, 670–676.PubMedCrossRefGoogle Scholar
  14. 14.
    Vert, J.P., et al. (2006) An accurate and interpretable model for siRNA efficacy prediction. BMC Bioinformatics. 7, 520.PubMedCrossRefGoogle Scholar
  15. 15.
    Gong, W., et al. (2006) Integrated siRNA design based on surveying of features associated with high RNAi effectiveness. BMC Bioinformatics. 7, 516.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press, a part of Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Muriel Golzio
    • 1
  • Laurent Mazzolini
    • 2
  • Aurélie Paganin-Gioanni
    • 1
  • Justin Teissié
    • 1
  1. 1.IPBS Université P Sabatier and CNRS (UMR 5089)France
  2. 2.CRPS CNRS- Pierre Fabre (UMR 2587)France

Personalised recommendations